Design of an Integrative Algorithm for Staging Tuberculosis
Launched by FUNDACIÓ INSTITUT GERMANS TRIAS I PUJOL · Sep 28, 2018
Trial Information
Current as of August 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving how we understand and manage tuberculosis (TB), a serious infectious disease that affects millions of people around the world, including many in Barcelona. The researchers want to create a new way to stage or classify the severity of TB using a comprehensive approach that takes into account various factors, including other health conditions and social influences. By doing this, they hope to enhance treatment and care for TB patients.
To participate in this trial, individuals must have a confirmed diagnosis of tuberculosis, meaning the disease has been verified through testing. They must also be receiving treatment at specific hospitals in Barcelona. The study is open to everyone regardless of age or gender, but participants must agree to share their data and samples for research purposes. Those who join the trial can expect to contribute to important research that may lead to better TB management in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • TB diagnosis (all forms), microbiologically confirmed (by AFB+, GenXpert+ or Culture+)
- • Clinical management of the patients being done at Servicios Clínicos, Hospital Universitari Vall d'Hebron-Drassanes or Hospital Universitari Germans Trias i Pujol.
- Exclusion Criteria:
- • Not consenting to data/samples donation
About Fundació Institut Germans Trias I Pujol
Fundació Institut Germans Trias i Pujol is a leading biomedical research institution based in Spain, dedicated to advancing health sciences through innovative clinical trials and translational research. With a strong commitment to improving patient outcomes, the foundation collaborates with academic, clinical, and industry partners to facilitate cutting-edge studies in various medical fields. Their multidisciplinary approach leverages state-of-the-art facilities and expertise to foster discoveries that translate into practical applications for healthcare, ultimately enhancing the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Badalona, Barcelona, Spain
Esplugues De Llobregat, Barcelona, Spain
Barcelona, , Spain
Barcelona, , Spain
Patients applied
Trial Officials
Cris Vilaplana, MD, PhD
Principal Investigator
Fundació Institut Germans Trias i Pujol
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials